Ivi Valencia S.L.
- Address
- lock Available on a paid plan
Female Urogenital Health and Pregnancy-Related Research
At Ivi Valencia S.L., clinical research is centered on Female Urogenital Diseases and Pregnancy Complications, with a strong focus on reproductive medicine and treatment support for women pursuing fertility care.
- Studies in female infertility and assisted reproductive technologies aim to better understand how to support women undergoing fertility treatment.
- Research involving women with an indication for IVF or ICSI is exploring ways to improve outcomes in in vitro fertilization-based care.
- Trials are assessing endometrial function, including how different forms of progesterone may influence uterine preparation and reproductive success.
The site is also evaluating treatments that may affect ovarian stimulation and uterine contractility, with the broader goal of improving fertility treatment effectiveness and understanding how the reproductive system responds to key therapies.
Fertility Treatment Optimization
Research at this hospital/clinic in Valencia is focused on improving the care of women undergoing fertility treatment, especially those receiving ART and related reproductive interventions.
- Work on female infertility is examining how reproductive treatments can be refined to better support patient outcomes.
- Trials in women undergoing IVF or ICSI are helping assess approaches intended to improve treatment response and clinical effectiveness.
- Studies of progesterone use are looking at its role in preparing the endometrium for implantation.
Additional investigations are testing how fertility-related therapies influence uterine activity and hormone-related responses, contributing to a clearer picture of reproductive health care.
Endometrial and Ovarian Response Studies
The clinical trial portfolio at Ivi Valencia S.L. includes research into how the endometrium and ovaries respond during fertility treatment, especially in the setting of controlled ovarian stimulation.
- Investigations of exogenous progesterone are focused on endometrial structure and function.
- Studies combining fertility medicines are evaluating whether treatment timing and pairing can improve reproductive outcomes.
- Research on uterine contractility is helping clarify how the uterus behaves during treatment cycles.
Together, these trials are designed to support better understanding of implantation conditions and the effectiveness of fertility-focused therapies.
Assisted Reproduction Research
This site’s Medicina Reproductiva department is conducting a small but focused set of trials aimed at improving care for women who need assisted reproductive technologies.
- Female infertility remains a key disease area, with studies looking at ways to enhance treatment support.
- Research in women undergoing IVF/ICSI is examining how fertility therapies can be used more effectively.
- Trials are also exploring the biological effects of medications used during ovarian stimulation and uterine preparation.
The overall research effort is aimed at improving reproductive outcomes by studying how the body responds to treatments commonly used in fertility care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Ivi Valencia S.L.1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Ivi Valencia S.L.2trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ivi Valencia S.L.
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effects of Nolasiban Dosing Regimens on Uterine Contractility and Endocrine Parameters in Women Undergoing IVF/ICSI | ReproNovo ApS | Phase II | Recruiting | Jun 2026 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Corifollitropin Alfa | 1 | Unknown | 2025-06-17 | 2025-06-17 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.